Ebenezer Berko, MD in Alexandria, LA - Medicare Internal Medicine

Ebenezer Berko, MD is a medicare enrolled "Internal Medicine - Hematology & Oncology" physician in Alexandria, Louisiana. His current practice location is 3330 Masonic Dr, Alexandria, Louisiana. You can reach out to his office (for appointments etc.) via phone at (318) 448-6917.

Ebenezer Berko is licensed to practice in Louisiana (license number MD.204538) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1154366508.

Contact Information

	Ebenezer Berko, MD
	3330 Masonic Dr, Alexandria, LA 71301-3841
	(318) 448-6917
	(318) 448-6866

Physician's Profile

Full Name	Ebenezer Berko
Gender	Male
Speciality	Internal Medicine - Hematology & Oncology
Location	3330 Masonic Dr, Alexandria, Louisiana
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1154366508
Provider Enumeration Date: 06/19/2006
Last Update Date: 06/28/2011

Medicare PECOS Information:

PECOS PAC ID: 3678500816
Enrollment ID: I20110721000046

Medical Identifiers

Medical identifiers for Ebenezer Berko such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1154366508	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RX0202X	Internal Medicine - Medical Oncology	036104008 (Illinois)	Secondary
207RH0003X	Internal Medicine - Hematology & Oncology	MD.204538 (Louisiana)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Ebenezer Berko allows following entities to bill medicare on his behalf.

Entity Name	Ochsner Clinic Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1538151428 PECOS PAC ID: 8224933619 Enrollment ID: O20031126000513

News Archive

PhaseBio initiates Glymera Phase 1/2a clinical trial in patients with Type 2 diabetes

PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has begun Phase 1/2a clinical testing with its lead compound, Glymera(PB1023), in patients with Type 2 diabetes.

Experimental MERS-CoV vaccine shows promise in monkeys and camels

National Institutes of Health scientists and colleagues report that an experimental vaccine given six weeks before exposure to Middle East respiratory syndrome coronavirus (MERS-CoV) fully protects rhesus macaques from disease. The vaccine also generated potentially protective MERS-CoV antibodies in blood drawn from vaccinated camels.

$4.5 million cost involved for MLSIC set up

The Michigan Economic Development Corp. (MEDC), Ann Arbor SPARK, Greater Wayne Economic Development Corporation and a private foundation have collaborated to create the Michigan Life Science and Innovation Center (MLSIC). MLSIC will connect well-funded, experienced entrepreneurs with business accelerator organizations and start-up life science companies.

Study delves into the role played by Protein Kinase C in synaptic plasticity

Inside the brain, is a complex symphony of perfectly coordinated signaling. Hundreds of different molecules amplify, modify and carry information from tiny synaptic compartments all the way through the entire length of a neuron.

Entity Name	Christus Health Central Louisiana
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1902088040 PECOS PAC ID: 4688570955 Enrollment ID: O20050906000593

PhaseBio initiates Glymera Phase 1/2a clinical trial in patients with Type 2 diabetes

Experimental MERS-CoV vaccine shows promise in monkeys and camels

$4.5 million cost involved for MLSIC set up

Study delves into the role played by Protein Kinase C in synaptic plasticity

Entity Name	Abbeville General Hospital
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1285779363 PECOS PAC ID: 8325933872 Enrollment ID: O20060217000566

PhaseBio initiates Glymera Phase 1/2a clinical trial in patients with Type 2 diabetes

Experimental MERS-CoV vaccine shows promise in monkeys and camels

$4.5 million cost involved for MLSIC set up

Study delves into the role played by Protein Kinase C in synaptic plasticity

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Ebenezer Berko is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Ebenezer Berko, MD 3330 Masonic Dr, Alexandria, LA 71301-3841 Ph: (318) 448-6917	Ebenezer Berko, MD 3330 Masonic Dr, Alexandria, LA 71301-3841 Ph: (318) 448-6917

News Archive

PhaseBio initiates Glymera Phase 1/2a clinical trial in patients with Type 2 diabetes

Experimental MERS-CoV vaccine shows promise in monkeys and camels

$4.5 million cost involved for MLSIC set up

Study delves into the role played by Protein Kinase C in synaptic plasticity

Internal Medicine Doctors in Alexandria, LA

Dr. Bruce W Barton, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 201 4th St Ste 3d, Alexandria, LA 71301 Phone: 318-473-9701 Fax: 318-473-9705
Dr. Hafez Halawani, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3330 Masonic Dr, Alexandria, LA 71301 Phone: 318-448-6917 Fax: 318-448-6866
Dr. Arun K Karsan, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 201 4th St, Suite 2d, Alexandria, LA 71301 Phone: 318-442-7867 Fax: 318-442-3015
Robert J Richards, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 211 4th St Ste 3f, Alexandria, LA 71301 Phone: 318-625-4149 Fax: 877-525-2516
Dr. Kelly Ryder Letsinger, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3330 Masonic Dr, Alexandria, LA 71301 Phone: 318-320-4422
Dr. Vikram Singh Nijjar, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2108 Texas Ave, Suite 2061, Alexandria, LA 71301 Phone: 318-448-1041 Fax: 318-448-0895
Dr. Naseem A Jaffrani, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 501 Medical Center Dr, Suite 250, Alexandria, LA 71301 Phone: 318-473-4613 Fax: 318-445-7129

Ebenezer Berko, MD - Medicare Internal Medicine in Alexandria, LA

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

PhaseBio initiates Glymera Phase 1/2a clinical trial in patients with Type 2 diabetes

Experimental MERS-CoV vaccine shows promise in monkeys and camels

$4.5 million cost involved for MLSIC set up

Study delves into the role played by Protein Kinase C in synaptic plasticity

PhaseBio initiates Glymera Phase 1/2a clinical trial in patients with Type 2 diabetes

Experimental MERS-CoV vaccine shows promise in monkeys and camels

$4.5 million cost involved for MLSIC set up

Study delves into the role played by Protein Kinase C in synaptic plasticity

PhaseBio initiates Glymera Phase 1/2a clinical trial in patients with Type 2 diabetes

Experimental MERS-CoV vaccine shows promise in monkeys and camels

$4.5 million cost involved for MLSIC set up

Study delves into the role played by Protein Kinase C in synaptic plasticity

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

PhaseBio initiates Glymera Phase 1/2a clinical trial in patients with Type 2 diabetes

Experimental MERS-CoV vaccine shows promise in monkeys and camels

$4.5 million cost involved for MLSIC set up

Study delves into the role played by Protein Kinase C in synaptic plasticity

Internal Medicine Doctors in Alexandria, LA